MANNELLO, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 14.665
EU - Europa 8.178
AS - Asia 3.068
OC - Oceania 25
SA - Sud America 21
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 25.992
Nazione #
US - Stati Uniti d'America 14.610
GB - Regno Unito 3.537
CN - Cina 2.190
UA - Ucraina 1.634
IT - Italia 701
SE - Svezia 589
FI - Finlandia 583
TR - Turchia 573
IE - Irlanda 350
DE - Germania 322
FR - Francia 243
RU - Federazione Russa 102
SG - Singapore 73
JP - Giappone 67
KR - Corea 65
CA - Canada 46
IN - India 36
NL - Olanda 26
AU - Australia 21
AT - Austria 19
EU - Europa 16
TG - Togo 15
PL - Polonia 14
VN - Vietnam 14
BE - Belgio 12
BR - Brasile 12
HK - Hong Kong 9
ES - Italia 8
ID - Indonesia 8
MX - Messico 8
BG - Bulgaria 7
IR - Iran 7
PT - Portogallo 7
SA - Arabia Saudita 7
NZ - Nuova Zelanda 4
PE - Perù 4
RO - Romania 4
CH - Svizzera 3
CL - Cile 3
MD - Moldavia 3
BD - Bangladesh 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
PK - Pakistan 2
TH - Thailandia 2
UZ - Uzbekistan 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
EC - Ecuador 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
TN - Tunisia 1
Totale 25.992
Città #
Southend 3.272
Woodbridge 2.336
Fairfield 1.962
Ann Arbor 1.503
Houston 1.380
Jacksonville 1.299
Chandler 940
Ashburn 785
Seattle 778
Cambridge 771
Wilmington 731
Nanjing 712
Izmir 432
Dublin 342
Nanchang 238
Helsinki 234
Princeton 196
Urbino 166
San Mateo 160
Beijing 158
New York 147
Boardman 132
Hebei 128
Shenyang 126
Jiaxing 119
Changsha 109
Istanbul 95
Tianjin 94
Kunming 86
San Diego 84
Velikiy Novgorod 83
Bremen 69
Seongnam 59
London 54
Hangzhou 40
Singapore 34
Düsseldorf 33
Mülheim 32
Shanghai 32
Changchun 30
San Francisco 30
Jinan 29
Norwalk 29
Toronto 29
Guangzhou 27
Auburn Hills 26
Lanzhou 24
Munich 23
Portland 18
Vienna 17
Zhengzhou 17
Redwood City 16
Lomé 15
Ningbo 15
Des Moines 14
Kilburn 14
Rome 14
Taizhou 14
Tokyo 14
Ancona 13
Montemarciano 13
Augusta 12
Dong Ket 12
Leawood 12
Brussels 11
Chicago 11
Melbourne 11
Acton 10
Civitanova Marche 10
Fuzhou 10
Monmouth Junction 9
Wuppertal 9
Islington 8
Los Angeles 8
Mergo 8
Amsterdam 7
Falls Church 7
Haikou 7
Kraków 7
Milan 7
Osimo 7
Riyadh 7
Washington 7
Bologna 6
Bonndorf 6
Borås 6
New Bedfont 6
Paris 6
Tolentino 6
Wuhan 6
Bielefeld 5
Canberra 5
Fano 5
Hanover 5
Hounslow 5
Saint Petersburg 5
Stara Zagora 5
São Paulo 5
Ardabil 4
Ascoli Piceno 4
Totale 20.679
Nome #
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 338
Analysis of the intraductal microenvironment for the early diagnosis of breast cancer: identification of biomarkers in nipple-aspirate fluids 237
Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development? 205
Chronic venous disease - Part II: Proteolytic biomarkers in wound healing 202
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 201
Breast cysts antitryptic activity 200
Chronic venous disease - Part I: Inflammatory biomarkers in wound healing 199
Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm. 198
Breast cyst fluid heparan sulphate is distinctively N-sulphated depending on apocrine or flattened type 196
Matrix metalloproteinase inhibitors as anticancer therapeutics. 195
Human gross cyst breast disease and cystic fluid: bio-molecular, morphological and clinical studies 192
Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease. 187
Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer 186
Aluminum induces inflammatory and proteolytic alterations in human monocytic cell line 186
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 185
Deciphering the single-cell omic: innovative application for translational medicine. 184
Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients. 183
Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine. 183
Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle 183
Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood. 183
Circulating immune complexes in human breast cyst fluids: relationship with intracystic immunoglobulin and electrolyte levels 182
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 182
Matrix Metalloproteinase Profiles in Chronic Venous Ulcer Wound Fluid of Inflammatory and Granulating Venous Leg Ulcers 182
Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases. 179
Melatonin reduces early changes in intramitochondrial cardiolipin during apoptosis in U937 cell line 178
The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms. 177
Ferritin and transferrin levels in human breast cyst fluids: relationship with intracystic electrolyte concentrations 177
Impact of blood sampling on the circulating matrix metalloproteinases 1,2,3,7,8, and 9 176
Pathophysiology of chronic venous disease. 175
Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. 175
Catalase expression in early human trophoblast 174
Gelatinase concentrations and zymographic profiles in human breast cancer: matrix metalloproteinases circulating in plasma are better markers for the subclassification and early prediction of cancer: the coagulation/fibrinolysis pathways alter the release, activation and recovery of different gelatinases in serum. 174
Ultrastructural characterization and biochemical profile of human gross cystic breast disease. 173
Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis. 172
uPA is upregulated by high dose Celecoxib in women at increased risk of developing breast cancer 172
The 'never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum samples. 172
Hydrogen peroxide cytotoxicity under conditions of normal or reduced catalase activity in H2O2-sensitive and -resistant Chinese hamster ovary (CHO) cell variants. 172
Benign breast diseases: classification, diagnosis, and management 171
Prostate-specific antigen expression in a case of intracystic carcinoma of the breast: characterization of immunoreactive protein and literature surveys 170
Immunoreactivity, ultrastructural localization, and transcript expression of prostate-specific antigen in human neuroblastoma cell lines. 170
Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic breast disease 169
Differential expression of MMP-2 and MMP-9 activity in megakaryocytes and platelets. 169
Hypoxia and neural stem cells: from invertebrates to brain cancer stem cells. 167
Pharmacologic treatment to improve venous leg ulcer healing 167
Blood sampling affects circulating TIMP-1 concentration, a useful biomarker in estimating liver fibrosis stages 165
Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer? 165
Lipids status in human breast cyst fluids 164
Aluminium and breast cancer: Sources of exposure, tissue measurements and mechanisms of toxicological actions on breast biology. 164
Phosphohydrolase analysis in human chorionic villi 163
Breast gross cystic fluids. II. Electron microscopic analysis 163
Detection of superoxide dismutase-1 in nipple aspirate fluids: a reactive oxygen species-regulating enzyme in the breast cancer microenvironment. 163
Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing 163
Aluminium, carbonyls and cytokines in human nipple aspirate fluids: Possible relationship between inflammation, oxidative stress and breast cancer microenvironment. 163
Tissue polypeptide specific antigen in human breast cyst fluids 162
Neural stem cells at the crossroads: MMPs may tell the way 162
Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome. 161
Goat immunoglobulin purification on phosphocellulose and DEAE affi-gel blue 160
Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches 159
Aluminium and human breast diseases. 159
Characterization of metalloproteinase-like activities in barnacle (Balanus amphitrite) nauplii 158
Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2 158
Zymographic analysis and characterization of MMP-2 and -9 forms in human sound dentin. 156
Electrophoresis of cholinesterases in early gestational amniocentesis 155
Hydroxyproline and creatinine levels in normal amniotic fluid 154
Nutrients and nipple aspirate fluid composition: the breast microenvironment regulates protein expression and cancer aetiology 154
Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. 153
Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer 153
Silicate increases the release of MMP-9 forms in peripheral blood: why gelatin zymography differs significantly in citrate plasma and serum obtained with or without clot activators. 153
Development and characterization of hydrogen peroxide-resistant Chinese hamster ovary cell variants--I. Relationship between catalase activity and the induction/stability of the oxidant-resistant phenotype. 152
Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids 151
Weight loss surgery improves the metabolic status in an obese rat model but does not affect bladder fibrosis associated with high fat diet feeding. 151
Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients 151
Lipid-associated sialic acid levels in human breast cyst fluids 150
Statins and breast cancer: may matrix metalloproteinase be the missing link 149
Electronegative LDL induces MMP-9 and TIMP-1 release in monocytes through CD14 activation: Inhibitory effect of glycosaminoglycan sulodexide 148
Multiple roles of matrix metalloproteinases during apoptosis 147
Characterization of amino acids and enzyme activities in early amniocentesis. 147
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 147
Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon? 146
Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer ? 146
Alkaline phosphatase expression in human chorionic villi 146
Prostate-specific antigen expression in neoplastic human myeloid cell lines 145
Breast cancer diagnosis by lactate dehydrogenase isozymes in nipple discharge 145
Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. 145
What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us? 144
PCR amplification and silver stain detection of genomic DNA fragments 143
Effects of blood collection methods on gelatin zymography of matrix metalloproteinases. 142
Characterization of CHO cells variants resistant to hydrogen peroxide 142
Conjugated bile acids in breast cyst fluids: relationship to cation-related cyst subpopulations 142
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles 141
Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study 141
Characterization of oversulfated chondroitin sulfate rich in 4,6-O-disulfated disaccharides in breast cyst fluids collected from human breast gross cysts. 141
Metalloproteinases and cytokines in endothelial dysfunction. 139
Chondroitin sulfate structure is modified in human milk produced by breast affected by invasive carcinoma 139
Zymographic analyses and measurement of matrix metalloproteinase-2 and -9 in nipple aspirate fluids 139
New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura 138
Serum or plasma samples? The Cinderella role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation 136
Nuclear localization of matrix metalloproteinases. 135
New horizon for breast cancer biomarker discoveries: What might the liquid biopsy of nipple aspirate fluid hold? 135
Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases 134
Totale 16.625
Categoria #
all - tutte 91.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.289 0 0 405 1.396 238 412 369 463 283 369 134 220
2020/20213.532 110 323 242 307 329 310 327 331 458 242 425 128
2021/20221.896 108 264 226 179 50 50 99 136 138 120 44 482
2022/20232.917 400 125 57 333 278 620 4 171 560 95 184 90
2023/2024801 83 59 64 82 62 179 45 59 4 88 17 59
2024/2025316 178 138 0 0 0 0 0 0 0 0 0 0
Totale 26.253